Research location
Kostroma
Russia
Advertisement
Research activity in Kostroma
RussiaCureCurrent currently publishes aggregate city-level research activity for this location: 15 trials and 15 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Kostroma
15 linked trials · page 1 of 1Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic AlterationsNCT06245837 · 2024-03-20 · 1 site observation
ACTIVE_NOT_RECRUITING
HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in RussiaNCT05905939 · 2023-05-31 · 1 site observation
COMPLETED
HER2-low Unresectable and/or Metastatic Breast Cancer in RussiaNCT05913440 · 2023-05-30 · 1 site observation
COMPLETED
A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin MelanomaNCT05751928 · 2023-04-05 · 1 site observation
ACTIVE_NOT_RECRUITING
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in RussiaNCT05887011 · 2023-03-31 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic MelanomaNCT05732805 · 2022-08-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in RussiaNCT05456867 · 2022-05-31 · 1 site observation
ACTIVE_NOT_RECRUITING
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in RussiaNCT04943497 · 2021-07-27 · 1 site observation
COMPLETED
Heart Failure Patients RegistryNCT04709263 · 2020-12-21 · 1 site observation
COMPLETED
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerNCT03701334 · 2018-12-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerNCT03539536 · 2018-10-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)NCT03521154 · 2018-07-19 · 1 site observation
ACTIVE_NOT_RECRUITING
An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2NCT02756832 · 2016-09-20 · 1 site observation
COMPLETED
International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of KazakhstanNCT02756819 · 2016-07-18 · 1 site observation
COMPLETED
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian FederationNCT02128334 · 2013-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.